The FAST Impact Award funds innovative translational research to advance therapies for Angelman syndrome from pre-clinical stages to IND application readiness.
The FAST Innovation Seed Grant funds early-stage, high-risk research to advance new therapies, targets, and biomarkers for Angelman syndrome.
The FAST-Trac Award from FAST funds cutting-edge translational research to develop and accelerate new treatments for Angelman syndrome, supporting projects that move therapies closer to clinical trials.
The Innovation Seed Grant from FAST funds bold, early-stage research to advance scientific understanding and treatment options for Angelman syndrome.
FAST’s New Investigator award funds early-career researchers advancing translational science and therapeutic innovation for Angelman syndrome.